aggressive antibiotic treatment and physiotherapy, she remained intermittently feverish, forced expiratory volume exhaled during the fi rst second dropped from 43% to 22% of predicted value and infl ammatory markers remained raised. Although consolidation had improved on chest x-ray, the bronchiectatic changes had worsened. CT of the chest showed dramatic deterioration in bronchiectasis throughout both lungs compared with CT 6 weeks earlier. and persistent antibiotic treatments alongside lung clearance therapies and nutritional support, the patient remains unwell and has not managed to regain her lung function.
DISCUSSION
Burkholderia cepacia complex (BCC) is a group of organisms closely related to pseudomonas species. More than 10 BCC genomovars are known to be pathogenic in cystic fi brosis. Genomovar III ( B cenocepacia ) is associated with accelerated decline in lung function. Other genomovars are thought to be less aggressive. Cepacia syndrome is a rapid clinical deterioration in patients with new acquisition of or chronic colonisation with BCC and carries a very high mortality. In chronically colonised patients, the deterioration is often triggered by an intercurrent illness. It is commonly associated with BCC genomovar III ( B cenocepacia ) but can very rarely be associated with B multivorans . To our knowledge, so far there have only been three published cases of cepacia syndrome in association with B multivorans . 1 
